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Biography  
Dr. Ross Hays is the director of the Seattle Children’s Hospital Palliative Care Service, 
the chair of the Ethics Committee, and a professor in the Department of Pediatrics.  
 
Dr. Hays trained at the University of Washington for his M.D., completed residencies in 
pediatrics, physical medicine and rehabilitation medicine, and a fellowship in birth 
defects. Dr. Hays has authored over 80 peer reviewed articles and abstracts, over 20 book 
chapters, has spoken at over 70 conferences domestically and internationally. 
 
Interview Abstract  
Dr. Ross Hays begins the interview by describing how he continued to pursue training 
after his pediatrics residency, transitioning to study birth defects, training in rehabilitation 
medicine, and finally training in bioethics. Dr. Hays was then recruited to become the 
principal investigator for a demonstration project by the Robert Wood Johnson 
Foundation titled Promoting Excellence in End-of-Life which finally allowed him to tie 
all his training experiences together. 
 
Dr. Hays then describes his observations that pain in pediatrics was recognized, but there 
was a lack of urgency in clinical need to treat pain—maybe in part due to that lack of 
sophistication in treatment paths for pain in the early 1980s. He also recalls that 
psychological and social support of pediatric patients and families were not typically seen 
as a necessary duty to fulfill by the medical community and largely became the 
responsibility of the family. 
 
The differences between primary and specialty palliative care are also defined by Dr. 
Hays as he describes how other hospital services met his palliative team with some 
suspicion and anxiety of his palliative service overstepping and usurping turf. He also 
explains that there will always be a need for palliative care due to the progression of 
medicine and more complex therapies available. When someone elects to complete these 
more complex therapies, they create the need for palliative care along their health care 
journey. 
 
Dr. Hays describes the most looming challenge for palliative services to be funding, 
especially outside of wealthy institutions that can support a palliative service that 
generally is not reimbursed well. Dr. Hays also describes that the best thing about the 
palliative field now is the new generation of well-trained leaders that are stepping up to 
take the lead. 
 
The interview concludes with Dr. Hays’ dream of having palliative services fully 
integrated and automatically consulted on every case of a leukemia or complex 
congenital heart disease or when a child goes on ECMO. He would like to see that 
palliative care professionals become viewed as integral parts of the medical team.  
  
Interviewer:  Bryan Sisk  September 3, 2019 
Interviewee:  Ross Hays  Page 2 of 20 
 
Glossary of Acronyms  
Abbreviation Definition  
CAR T-Cell Chimeric Antigen Receptor T (T-
lymphocytes) Cell Therapy 
ECMO Extracorporeal membrane 
oxygenation 
Heme/onc Hematology/oncology 
ICU Intensive care unit 
IPPC Initiative on Pediatric Palliative Care 
NICU Neonatal intensive care unit 
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[00:00:00] 
Bryan Sisk:   Today is September 3, 2019.  I am Bryan Sisk.  I am in St. Louis, 
Missouri interviewing Dr. Ross Hays for the Pediatric Palliative 
Care Oral History Project. Dr. Hays is in Seattle, Washington.  
Thank you, Dr. Hays, for joining me today, to get us started could 
you just tell me when you mind turned toward pediatric palliative 
care as a career focus? 
 
Ross Hays:  I believe it was around 1997 when my organization, Seattle 
Children's Hospital, was interested in competing for an award 
through the Robert Wood Johnson Foundation Promoting 
Excellence in End-of-Life Program. These were demonstration 
projects that were going to be funded by The Robert Wood Johnson 
Foundation and a group at people at Seattle Children's drafted me to 
be the principal investigator on that project. I think that as a career 
focus, I suppose, that's where it started. I'll say that earlier on—I 
have additional training in bioethics. Around 1991 as part of a 
bioethics effort, was exposed to Elizabeth Latimer when she came 
to Seattle to give a lecture. She was the first person I really heard 
talk about palliative care as a clinical service. That was much earlier, 
that was maybe, around 1991.  
[00:02:04] 
Bryan Sisk:  You have an interesting background where you studied pediatrics 
and then birth defects and then did physical and rehabilitation 
medicine training. How did all that fit into your career before ethics 
and palliative care came more of the forefront? 
 
Ross Hays:   Good question. It doesn't appear to be a logical connection, but in 
doing pediatrics and rehabilitation medicine, one of the areas where 
I gravitated and eventually specialized was in progressive 
neuromuscular disease. My clinical focus was children with spinal 
muscular atrophy and muscular dystrophy. In the late-80s to early 
90s, or even before that, in the 80s I should say, the majority of those 
patients died at a young age. Spinal muscular atrophy.  Type I 
patients usually didn't live through their first birthday, Duchenne 
patients didn't usually live to be 20, and so providing comprehensive 
care for them included some aspect of palliative care, even though 
we really didn't call it that. So that was my clinical focus. I had a 
very thoughtful chairman who first recognized in me that I had this 
interest in the larger view of this population. One time he told me, 
he said, "You agonize over these children. I think you need to learn 
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how to agonize more constructively." He introduced me to Al 
Johnson, who was the Chair of the Department of Bioethics and 
Humanities here at Seattle Children's, and that's when I started my 
bioethics training. The bioethics training and the experience in 
caring for children with serious life ending illness that I got through 
my rehab clinical work really was the clinical foundation for moving 
ahead with palliative care.  
[00:04:51] 
Bryan Sisk:   Before you were volun-told that you were going to be the PI 
[principal investigator] for this Robert Wood Johnson Foundation 
End-of-Life Excellence program, before that, had you already 
established in your own mind that, "I'm really interested in and 
going to focus on the suffering in this end of life care," or was it that 
you had an interest but it didn't become as apparent until you 
volunteered for that? 
 
Ross Hays:   No, I think I had an interest before that. As I mentioned I was 
exposed to the concept of palliative care in general much earlier than 
that. I was also doing clinical work at the University of Washington 
Pain Center, where I was involved in pain and symptom 
management, before, primarily patients with chronic pain. I did that 
for eight years and I started that in 1993, and so, began to develop 
some of the fundamentals of understanding how to do pain and 
symptom management in that setting. I also had a chance there to 
meet another physician, Stu Farber who was then a Project On 
Death in America PDIA Fellow. That was a program started through 
the Soros Foundation. I think I got a healthy exposure to the field 
earlier on through Stu and through my opportunity to work with pain 
patients.  
[00:06:32] 
Bryan Sisk:   When you were starting out, let's say when you got to the late-90s 
and you were starting to PI this End-of-Life Excellence project, did 
you find a community of similar minds at that time? 
 
Ross Hays:   Yeah, as I said I was sort of drafted for this project, and there were 
two nurses who became the managers of the project and were very 
committed to this. Other names were Mo Palmetto and Gerri 
Haynes. And Gerri Haynes in particularly had a lot of experience. 
She had as a hospice nurse, worked on the development of a free-
standing hospice facility here in the Seattle area, and was very, very 
familiar and committed to that. She then was part of—she and Mo 
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Palmetto together were funded by an organ of our hospital, which 
was then called The Office of Children with Special Health Care 
Needs. As part of that, they did a statewide assessment of pediatric 
death in Washington State. They spent two years gathering data 
about how many children die in our state, what their most common 
diagnoses are, place of death, and then followed that up with a 
qualitative study where they interviewed bereaved families to find 
out what their needs were and that was sponsored by this Center for 
Children's Special Health Care Needs. They were very much 
committed to the idea of improving end-of-life care for children and 
became my closets colleagues.  
[00:08:45] 
Bryan Sisk:  Sounds like Seattle was really ahead of the times at that point. Did 
you have a lot of colleagues at other institutions who had similar 
experiences? 
 
Ross Hays:  No, if you've been talking to some of the people, some of the leaders 
here, some of the leaders of our field, like Joanne Wolfe and Chris 
Feudtner. Chris Feudtner actually at that time was a Robert Wood 
Johnson scholar here in Seattle. He had done his pediatric residency 
here and went on to get an MPH through the program that's no 
longer available. But when Chris was here at Seattle at that time and 
got similarly drafted into this project. We worked together, we 
actually applied for PDIA fellowships together and didn't get one, 
but we worked on a number of other things.  And then, as you know, 
he went on to Children's of Philadelphia and has established quite 
an important new national reputation as a palliative care specialist.   
[00:10:03] 
Bryan Sisk:   Who did you learn from as you were focusing on end-of-life and 
what would become palliative care? 
 
Ross Hays:   [laughs] I think we kind of, had to all teach each other. In the 
beginning I think it was a matter of going to what we had in the 
literature and then our shared experience. I think in the beginning it 
was really an opportunity to be on auto didact. I mean we had to 
learn from each other. The American Academy of Hospice and 
Palliative Medicine was a very tiny organization then, and we would 
go to their meetings and you would gather information from that 
and, from wherever. Also being part of that larger Robert Wood 
Johnson Promoting Excellence and End-of-Life Care program, that 
program sponsored end-of-life opportunities for all of us to get 
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together. At least twice a year they would bring all of the PIs together 
and we would compare notes and we would learn from each other 
and so, there were opportunities like that. There was also, right 
around the 2000 or so, there was effort around called the Initiative 
on Pediatric Palliative Care, the I-P-P-C. They were doing a lot to 
educate people particularly about pediatric palliative care. I 
remember, I think it was in the spring of 2004, they sponsored a 
conference where they brought people who were doing this. I don't 
know if you could say leaders in the field, but people who were 
doing this altogether at a big conference in Massachusetts where we 
had an opportunity to kind of, learn from each other. There were a 
couple of organizations out there that were leading the way in terms 
of providing the beginnings of an academic foundation for the field.  
[00:12:31] 
Bryan Sisk:   I just want to take a second to go back a little further. You had 
finished medical school in '78 and then started your residency 
program at Brown I believe, after that. Around that time when you 
just beginning your clinical work, what were the biggest challenges 
that you observed caring for suffering and seriously ill and dying 
children? 
 
Ross Hays:    When I was a trainee at Brown? 
[00:12:56] 
Bryan Sisk:   Just back around the late 70s or early 80s when you were first getting 
into this, what do you recall as challenges in caring for these kids at 
that time? 
 
Ross Hays:   That's a really good question. I think hematology oncology probably 
had made some headways in understanding the language of the 
hospice and palliative care for children, but it was relatively 
primitive then. Death in childhood is pretty unusual and the Brown 
program was really a generalist training program, so where we 
would encounter end-of-life would be in heme/onc [hematology 
oncology] and in the NICU [Neonatal intensive care unit] and rarely 
elsewhere. There wasn't a lot of sophistication in understanding 
things like incorporating family preferences into end-of-life care or 
understanding end-of-life care as a concept by itself. I think that 
those were really nascent at that time. I mean there was a lot of room 
to improve on the situation as it was back then.  
[00:14:46] 
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Bryan Sisk:   What about pain in children? How effectively was pain managed 
earlier on?   
 
Ross Hays:   Variably, I think. Probably not well and probably not nearly as well 
as it is now. Again, that was quite a long time ago and so there 
weren't as many choices in pain management as we have now. I think 
that people didn't really recognize the importance of managing pain 
and symptoms as much as we do. There wasn't much of an emphasis 
on it then as there is now. I don't think that we were doing 
particularly well. Joanne Wolfe published a paper in 2000.  It said 
that although all children with cancer who died in their institution 
who treated for pain, only 50% of them felt like they've been 
effectively treated for pain, and that 80% of them had experienced 
suffering in the last few weeks of their lives. I don't think we were 
doing as good a job. I think it was we didn't know what questions to 
ask. I think we weren't educated. We were afraid of opioids. There 
were just a lot of reasons why we didn't do a better job.  
[00:16:24] 
Bryan Sisk:   What about psychological and social needs, did those receive a lot 
of attention in pediatrics in the early 80s in your experience?   
 
Ross Hays:   I don't think they did universally. I don't think it was really 
recognized as part of what the medical community needed to offer.  
I think there were families that were very resourceful and found their 
resources and did a remarkable job. Then I think there were other 
families who didn't have those resources and didn't know where to 
look and didn't have a lot of help from the medical side, and so I 
think they probably suffered a fair amount. I think in those early 
stages, whether you got good social, psychological, spiritual support 
really was dependent on how resourceful the family was. It really 
wasn't seen as a responsibility of the medical team. I think it was 
much more the medical side was tasked with doing the best they 
could to treat the disease, but the larger picture of the whole human 
experience of end-of-life wasn't really—I don't think it was really 
understood to be a medical responsibility.   
[00:17:55] 
Bryan Sisk:    Following up on that, did clinicians at that time have an awareness 
or you have the terminology of suffering when thinking about kids?   
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Ross Hays:   I don't think anybody missed the fact that children were suffering. I 
think the medical providers were suffering too, it's just that I don't 
think we had the tools to be more constructive about it.   
[00:18:29] 
Bryan Sisk:    You said earlier agonize more constructively.   
 
Ross Hays:   [laughs] Yeah, that was my chairman. He was very insightful.   
[00:18:40] 
Bryan Sisk:   I also wanted follow-up on that, agonizing more constructively led 
you to bioethics. I am interested, has your continued role in bioethics 
and your role in palliative care, have those complimented each other 
or have they led to any tension? 
 
Ross Hays:   I think they're more complimentary than they are in opposition to 
each other. I think there are many, many bioethical questions that 
come up in end-of-life care, so having some facility with both I think 
is a helpful thing. I do think that if you're being a provider who is 
participating in both, so that would be like bioethics consultation 
and palliative care consultation, I think there is an important part 
about keeping those two separate. The big difference for me is in 
bioethics consultation, you want be as objective as you can be and 
often you're called to be a third-party observer in clinical disputes or 
in an ethical question where there might be one or two different 
factions or sides that are trying to influence a solution. And so 
objectivity is very important in bioethics consultation.  
 
In palliative care consultation, it's sort of the opposite. I mean very 
often we find ourselves being advocates for the family, the patient 
and the family. And sometimes we have to insert ourselves into the 
clinical conversation to be sure that families have clear information 
and understanding about the choices that they're making and the 
decisions that they face and that in situations where there may be a 
bias that's inherent in the clinical treatment, that the families 
understand that they still have final authority to consent or not to 
treatment or to change the course of treatment. In my experience in 
palliative care consultation you forfeit your objectivity 
appropriately so that you can be a more effective advocate for the 
patient and family. So answering your question, I think the two of 
them work together. I think bioethics informs palliative care, 
palliative care provides a lot of clinical material for bioethics and so 
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they go together in that way. But when you're actually doing clinical 
consultation there are important reasons to keep them separate.  
[00:22:01] 
Bryan Sisk:   How did your clinical career develop? You started in rehab medicine 
and then you started in with more and more ethics, so did you 
continue doing rehab medicine overtime? How did that all progress? 
 
Ross Hays:   Pediatric disability or pediatric rehabilitation is the job that I was 
hired to do, so I continued to do that. But as the palliative care 
service began to increase, I did have the flexibility to gradually 
increase my palliative care clinical work and gradually decrease my 
pediatric rehab work. That was a luxury that was provided to me by 
my very generous institution, Seattle Children's Hospital—have the 
ability to give me that flexibility, and so it was a very gradual 
progression. I'll tell you that I only disengaged completely from the 
pediatric rehab department a month ago, or 2 months ago in July, so 
I continued do participate in that Department primarily as an 
outpatient clinic provider until this summer.  
[00:23:43] 
Bryan Sisk:   What do you think were the biggest challenges you faced as you 
started developing this pediatric palliative care niche? 
 
Ross Hays:   I think in the beginning it was establishing the legitimacy of what 
we did. I think that when you have new service that adds value to a 
system that already exists, then sometimes you have to state your 
case; you have to prove that what you're doing adds value. So for 
example, in the course of caring for pediatric cancer patients, the 
heme/onc providers who provide the clinical treatment for cancer 
would feel that they were not only experts at providing cancer 
treatment, but they were also experts at providing end-of-life care 
for their patients if they're treatment didn't work. And so they 
already had that role and identified with it. Then when you come in 
and say, "We're going to provide palliative care," it would be very 
natural for the hematology oncology providers to say, "We're already 
done that. We don't need you. You're not necessary here." And if 
from our point of view, what we had to offer was a way to do it 
better, you have to be very careful about how you promote that. 
Because it's very easy for someone who's been involved in that 
aspect of care for a long time to look at any offer of additional help 
that would be an improvement as a statement on what they are 
already doing, if you understand what I'm trying to say. By saying, 
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"Oh, yes we have palliative care. We believe that we could add value 
to end-of-life," it could be interpreted by those who are already 
providing that care as well, "You're saying that we're not doing it 
well enough," and that puts people on the defensive. We often 
experienced that I would say to some degree from physicians, but 
really very strongly from our colleagues in social work. They really 
were often not appreciative of us trying to add on to what they were 
already doing. It was interpreted as a statement that what they were 
doing wasn't good enough. And we never, ever intended it to be that 
way of course, and it wasn't that way, but there is that possibility of 
interpreting that way. To answer the question, I think it was our 
biggest barrier. I think we just had to continue to do the work and to 
believe in the value in what we were doing and let the work speak 
for itself and eventually that resistance went away.   
[00:27:36] 
Bryan Sisk:   What were your best practices, looking back the best things you did, 
that allowed you to get beyond that resistance? 
 
Ross Hays:   Sometimes it was always being supportive. If we got a request to 
meet with the patient and the family, we would always be diplomatic 
and explain to the referring team why we were there and what we 
were doing, and be very intentional about the fact that we were 
partnering with them and then we had no interest in competing for 
the family’s affections or trying to move the patient over to our own 
service and to interfere in any way to the relationships that had 
already been developed between the patient and the family and their 
providers. We always, always would bend over backwards to be 
cooperative and to be as open as and to communicate as effectively 
as we possibly could with the referring service. It's funny Joanne 
Wolfe used to say that, "50% of pediatric palliative care is 
diplomacy." And I really believe that, that is still true for us. I mean 
we are very respectful of the services their request us, whether it is 
in the ICU [intensive care unit], the neural muscular disease service, 
the hem/onc service, or bone marrow transplant team, whatever; 
very, very respectful of the fact that they asked us to come in and 
very reluctant to do anything that looked like it would interfere with 
that relationship. So I truly believe that 50% of pediatric palliative 
care is diplomacy. I was at a meeting Joanne and we were talking 
and I quoted that, and she said, "No, that's not right."  I said, "Well 
Joanne how can you tell me that's not right?  I learned that from 
you." And she said, "it's because it's 80%." And I thought, "Okay." 
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[laughs] That is the way you have to do it. Often I felt what we were 
doing is enter into a situation, we'd recognize there was some 
deficiency there, maybe the pain wasn't being managed adequately 
or maybe the family was in the dark about some critical decision or 
the communication between the medical team and the family had 
not been thorough. We'd recognize something to be addressed and 
sometimes the best way to that was to find a way to put that idea in 
the head of the person who asked us to get involved. If it was the 
ICU attending who we recognized wasn't really communicating 
with the family and the family was not really getting what they 
needed, we would find a way to make that attending aware of the 
fact that she needed to do more in some kind of subtle way and then 
watch her do it and then congratulate her for being so thoughtful and 
being so proactive. And that was often the way you would make 
progress for patients and families. And it requires a certain amount 
of humility because you could just never take credit for what your 
work was, because you had to make it look like it belonged to 
somebody else.  
[00:31:38] 
Bryan Sisk:    Has that changed overtime or is that still the same? 
 
Ross Hays:   I think there is still an element of that. But you know there's this 
newer concept now that I think really came from Timothy Quill 
about specialty palliative care and primary palliative care. Specialty 
palliative care is what we're trained to do—it's more complicated 
pain and symptom management and it's a more aggressive way of 
recognizing ways to improve communication and provide 
continuity. I mean those are the things that a palliative care 
fellowship trains you to do, and so that's specialty palliative care. 
 
Primary palliative care is basically the attitude of creating an 
environment that promotes better care at the end-of-life. So it is 
improved communication, it is a basic understanding of pain and 
symptom management, and it's something that everybody, every 
provider should have, and I know you're aware of this. I think what's 
happened over the last decade and so is that, there's been this 
development of specialty palliative care as a specialty, but there's 
been I think great improvements in the whole concept of primary 
palliative care too. I think the quality of care in both aspects 
specialty and primary palliative care has risen overtime and so. I 
think there are more people who are more thoughtful about the way 
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they are treating patients at the end of life and so, I think that our job 
is not quite as obvious as it was 20 years ago.   
[00:33:38] 
Bryan Sisk:   Looking more globally from your perspective, what do you think 
was the spark that really drove the development of pediatric 
palliative care as a specialty? 
 
Ross Hays:   I think that palliative care in general, I mean I think we got to the 
point in the 90s where I think the whole medical community, really 
led by the Soros Foundation and the Robert Johnson Foundation, 
began to look at the way we managed end-of-life care and 
collectively said, "We suck at this." And that's when, particularly 
those two agencies, but others got on board and said, "We need to 
take this on. We need to make improvements here." And so that was 
in the early to mid-1990s, that was American health care in general. 
And we didn't have to look to far to find better systems. I think 
Canada was already ahead of us. I think the U.K. was ahead of us in 
terms of more enlightened hospice care and more attention to end-
of-life care. So that happened in the early to mid-90s, palliative care 
in general.  
 
I think in pediatric palliative care there were a few pioneers really 
who took this on and led the way. People like Pam Hinds in 
Washington D.C. and Joanne Wolfe certainly, but others; Ann 
Goldman in the U.K. It was individual people who recognized there 
was a need for this and I think because it was mostly in academic 
centers, not only did they initiate the clinical service, but they 
initiated an academic approach to it with research and education as 
being a component of the specialty from the very beginning. I think 
that's what happens when you have a brand new specialty that 
develops at this day and age. We know enough now to realize that 
you just can't go out and do the clinical work; you have to provide I 
think the academic justification for it at the same time, and so very 
thoughtful people did that. Bruce Himelstein was another person 
who took this on very early on. He's not doing it anymore now, but 
there were people, individuals I think, who were largely responsible 
for getting this off the ground.  
[00:36:29] 
Bryan Sisk:  You had mentioned the Robert Wood Foundation and the Soros 
Foundation, how important were these funders in the development 
of pediatric palliative care? 
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Ross Hays:  Well I think they were very important legitimizing palliative care in 
general, not so much pediatric palliative care. Robert Wood Johnson 
Foundation Promoting Excellence in End-of-Life Care, they had 
like 760 letters of intent from different organizations wanting to do 
a demonstration project and they chose 22 to fund. Each one of them 
was funded for three years and of those 22, only two were pediatric, 
so that was here at Seattle's Children's and at Cardinal Glennon 
Hospital in St. Louis. I think those agencies were very important in 
the development of palliative care in general, and hospice too and 
actually, I think in broadening the view of hospice. But I think 
pediatric palliative care wasn't the target of those agencies and it 
shouldn't have been. I mean when you think about it, pediatric 
palliative care is a tiny, tiny subset of palliative care in general.  
When do people die? They die when they're old, and so palliative 
care in general is quite big, but pediatric is a really small subset, it's 
a very intensely different subset. We're small compared to palliative 
care in general.  
[00:38:11] 
Bryan Sisk:   And thinking more about palliative care in adult hospice, how much 
do you think the adult hospice movement affected the development 
of pediatric palliative care? 
 
Ross Hays:  I think minimally. They had enough on their plates already trying to 
improve care for adults at the end-of-life, which is again, that is the 
industry. I think it was a few enlightened individuals who really 
emphasized pediatric hospice care. We here in Seattle were lucky 
there was a visionary person in our hospice community here who 
recognized that there needed to be a dedicated pediatric hospice 
program and she really made the case and found a willing sponsor 
and developed a dedicated community-based pediatric palliative 
care and hospice program. And so, we've had that here in Seattle for 
probably 15 years or so, but that's not the case everywhere else. I 
mean even in large Metropolitan areas, like in Boston, Philadelphia 
and New York, there aren't dedicated pediatric hospice programs. 
There are hospices that provide care to children occasionally and it's 
a continual issue for them because those hospices who have nurses 
primarily who are familiar with adult hospice and very comfortable 
doing that, don't feel very comfortable taking care of children, and 
so, they really rely on organizations like the palliative care programs 
at Children's of Philadelphia or Boston Children's or Seattle 
Children's, to provide the extra expertise that they need to be able to 
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do this. So pediatric hospice care, it's just really small, and so there 
are relatively few pediatric programs. Trinity Health in Los Angeles 
is a great example of one that's been very successful. The 
Steppingstones Program here in Seattle is the one that I mentioned, 
is 15 years old now and is really quite successful, but it really took 
a visionary person to make it happen.  
[00:40:55] 
Bryan Sisk:   How has interactions been between hospital-based programs, 
especially in pediatrics, and the community-based programs? 
 
Ross Hays:  I think in my observation good, generally. We share a mutual need, 
which is the best interest of our patients. Palliative care programs 
within hospitals are anxious for children to be able to spend their 
final days in the setting that's most appropriate for them and for 
many of them that's home. And so, it's our responsibility to allow 
them to have that experience. We have a vested interest in getting 
those children out of the hospital and home where they want to be 
and to have them cared for appropriately once they get there. So we 
have a strong interest in promoting community-based programs. 
And the community-based programs, at least in my state, are 
mandated to take children. The Certificate of Need for Hospice in 
the State of Washington includes a clause that says that, "There 
could be no discrimination based on age." So that means a hospice 
that takes 99% older adults is required to take a pediatric patient if 
it's referred in their catchment area. So they often look to us for 
support and help in how to manage these kids. I think the we 
mutually depend on each and our shared goal is to try to create the 
best outcome for our patients and their families.   
[00:42:54] 
Bryan Sisk:   Looking over your career from the late-70s to date, what do you 
think have been the biggest changes in care that we provide to these 
kids that are suffering and dying? 
 
Ross Hays:   [laughs] Wow. Well I think that the fact that we do have pediatric 
palliative—well, between the 1970s and now, the fact that we have 
pediatric palliative care at all. It did not exist obviously, when I 
started my training or even when I stared as an attending physician. 
So the biggest change is that we have this specialty with all of the 
expertise and experience and authority and education that it has. The 
answer to your question would be simple. We have this specialty that 
makes a difference. To dive in a little deeper, I think that children 
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die differently now than they did in the 70s. I think back then, 
children would often die in the hospital, it was pretty rare for them 
to die at home. I think we had less ability to prognosticate and to 
plan for end-of-life care. I'll just give you an example that came up 
recently. 
 
In the late-70s when a child was born with hypoplastic left heart 
syndrome, which is a fatal congenital cardiac condition, the babies 
would be born, they would be okay for a few hours and then they'd 
start getting sick. There would be some kind of emergency work up. 
You would realize, "Oh my gosh, this baby has only one ventricle." 
And you would gather up the family and say, "Oh, we're so sorry 
there's nothing we can do." And the baby would live for a day or so. 
And that was hypoplastic left heart. Well now in 2019, number one, 
those children are diagnosed at 20 weeks gestation. They're 
diagnosed long before they're born, and then there's an opportunity 
to plan for their delivery. They're delivered in a high-risk center and 
then there are a series of three very complicated surgeries available 
to the family. So the family can be counseled, "Yes your baby is 
going to have rough road ahead, but it's certainly not going to be 
fatal, and the likelihood is your child is going to live, and maybe live 
through these three surgeries and maybe on to have a heart transplant 
and end up in college and beyond." So there are those kinds of 
developments that create an entire need for palliative care.  
 
I mean if you define palliative care broadly, which includes multi-
disciplinary supported continuity of care throughout the trajectory 
of the illness and assisted decision making, than pediatric palliative 
care for that child with hypoplastic left heart begins about five 
months before that baby is born and then continues on through all 
of those different phases of treatment. It's an entirely different 
ballgame. Now again, back in the 70s, if you were treated for acute 
lymphoblastic leukemia and then you relapsed, often you'd die. Now 
if you’re treated and you relapse, then you go on to a more intensive 
chemo therapy regimen. And then if you relapse again you go on to 
bone marrow transplant. And then if that fails, then you usually have 
a second bone marrow transplant. And if that fails then you're 
referred on to CAR [Chimeric Antigen Receptor] T-Cell therapy. 
And so these diseases that were once quite short and fatal are now 
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prolonged and variably successful and so they create and entire need 
for palliative care along the way. So lots of changes.  
[00:48:00] 
Bryan Sisk:   Looking at your career what is your favorite contribution to this field 
that you've made? 
 
Ross Hays:    [laughs] Survival? Maybe survival would that be it? The thing that 
is most gratifying is that when I started, it was just kind of an uphill 
struggle.  You knew you were doing the right thing but half the time 
you really had to devote your energy to convincing somebody else 
that it was the right thing. I don't really feel like we face that 
anymore. Now, we have a new generation of bright, young, well-
trained physicians who want to this work and they're not having to 
blaze the trail anymore. I think the pathway is already there, they 
just now really get to do the work, which I think is a great thing.  
[00:49:05] 
Bryan Sisk:   What do you think are the biggest challenges that still face the field 
right now? 
 
Ross Hays:   Well we're in a medical economic system that doesn't value what we 
do. And you can say that about all kinds of different aspects of health 
care, we don't get paid for what we do. I always say if we could 
provide palliative care consultation and colonoscopy, then we'd be 
great because we would have a well-compensated procedure and 
then we would never have to worry about money. But palliative care 
programs, they add value but they don't generate revenue in our 
system, and so they are variably precarious. I'm fortunate here at 
Seattle Children's, we have a very generous hospital that recognizes 
the value of what we do, and the fact that we don't bring in enough 
money to offset our expenses has never been limitation or hasn't 
been a big limitation, and you work with adjusting. At St. Jude it's 
similar. They have the economic wherewithal to support this, but it's 
not true everywhere and there are other programs that really are 
struggling and are very precarious because their administration 
doesn't recognize the value and they don't have the resources to 
essentially support a loss leader. And so I think that in our present 
system, the biggest barrier or the biggest threat or the biggest 
challenge is to have a robust reimbursement system that supports 
this everywhere, not just at wealthy children's hospitals like at St. 
Jude's that can pay for almost anything.     
[00:51:18] 
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Bryan Sisk:   Looking at the whole field again, in what areas do you think the field 
is the strongest? 
 
Ross Hays:  I think it's the strongest in the commitment of this young generation 
physicians who are doing the work. For over 10 years I was the only 
palliative care doc here. Now there are eight at Seattle Children's, 
and the other seven are all a generation younger than I am. And 
they're well trained and they are interested in making a contribution 
and they're getting additional training in methodology and research 
experimental designs, statistical analysis so that they can improve 
the value of what we do. And so I think this generation is by far the 
best thing that can happen to pediatric palliative care.  
[00:52:16] 
Bryan Sisk:   And then the last question, I would really love you to dream aloud. 
So if budget, politics, reimbursement and all the other things that we 
talked about weren't an obstacle, what would you want care for these 
children to look like in another 10 years? 
 
Ross Hays:   I think I want it to be a seamlessly integrated system where pediatric 
palliative care is recognized as one part of every bone marrow 
transplant, one part of every complex congenital heart disease, one 
part of the care for all children with leukemia at relapse, so that you 
really don't require consultation anymore, you are just part of the 
team. We don't apologize for the fact that we have a dietitian on the 
leukemia team, that's just assumed that that's normal. We don't 
apologize for the fact that we have a physical therapist on the cancer 
care unit or that we have a social worker attached to the brain tumor 
unit. We don't apologize for those things because we've all 
recognized they are a necessary part of the team, that they have a 
role to play, and they really don't require any justification anymore. 
In my ideal world, pediatric palliative care, we have that same status.  
I really think I’m not exaggerating when I say that after 20 years at 
Seattle Children's we're pretty close to that. We're just integrated into 
the care these high risk groups, we have an automatic seat at the 
table for all the high risk leukemia admissions, we are consulted for 
every bone marrow transplant. We are automatically consulted when 
we have a child that goes on ECMO [Extracorporeal membrane 
oxygenation]. I think, at least at our place, we're close to realizing 
that goal, but I don't think that's true everywhere. The ideal state 
would be where pediatric palliative care is recognized as a necessary 
treatment for any child who has potential life limiting illness. It 
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doesn't require consultation, it doesn't require justification, doesn't 
require anything. We're just part of the game.  
[00:54:53] 
Bryan Sisk:   Those were all of the questions I have, but is there any area of this 
history that you think that I should dig into deeper in the future? 
 
Ross Hays:   I don't think so. I'm going to be really interested to see what you 
come up with because I suspect that you're getting different stories 
from people at different places, which I think should be quite 
interesting.  
[End of Audio]  
